← Leaderboards
David M Kerins
Vanderbilt University
$6,093
Attributed
$6,093
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$6,093 · 3
By mechanism
M01$6,093 · 3
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Joshua C. Denny$39,465,922
- Mia A. Levy$4,206,959
- T A Ikizler$257,268
- Josh F. Peterson$25,101,962
- Charles M. Stein$20,921,975
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectChemopreventionCoagulation Factor VWarfarinCardiovascular Disorder PreventionThromboembolismDrug Screening /EvaluationHeart Disorder ChemotherapyBlood /Lymphatic PharmacologyHuman Therapy EvaluationInhibitor /AntagonistIntegrinsOral AdministrationPharmacokineticsPlatelet Aggregation InhibitorsAcute Disease /DisorderCoronary Disorder
Grant awards (11)
Prenvention of Recurrent Venous Thromnoembolism$5,501
M01 · FY2004 · RR
ORAL RPR 109891 FOR 8 WEEKS IN ACUTE CORONARY$0
M01 · FY2002 · RR
PREVENTION OF RECURRENT THROMBOEMBOLISM$0
M01 · FY2002 · RR
PREVENTION OF RECURRENT THROMBOEMBOLISM$0
M01 · FY2001 · RR
ORAL RPR 109891 FOR 8 WEEKS IN ACUTE CORONARY$0
M01 · FY2001 · RR
ORAL RPR 109891 FOR 8 WEEKS IN ACUTE CORONARY$0
M01 · FY2001 · RR
ORAL RPR 109891 FOR 8 WEEKS IN ACUTE CORONARY$0
M01 · FY2001 · RR
PREVENTION OF RECURRENT THROMBOEMBOLISM$0
M01 · FY2001 · RR
PREVENTION OF RECURRENT THROMBOEMBOLISM$0
M01 · FY2001 · RR
PREVENTION OF RECURRENT THROMBOEMBOLISM$592
M01 · FY2000 · RR
ORAL RPR 109891 FOR 8 WEEKS IN ACUTE CORONARY$0
M01 · FY2000 · RR